Home › Arena- Belviq Scripts Continue Troubled Path
 

Keywords :   


Arena- Belviq Scripts Continue Troubled Path

2016-03-02 00:47:30| Biotech - Topix.net

Arena investors that have been following my coverage of Belviq sales should not be surprised by what this week's numbers delivered. Some Arena investors got a big surprise yesterday when it was revealed in a quarterly conferece call that Arena's marketing partner Eisai is essentially running a bare bones effort until after the data from a CVOT trial is released in 2018.

Tags: continue path scripts arena

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
10.05BeautyHealth: Q1 2024 Financials
10.05Research Institute for Fragrance Materials to Promote Online Database on May 22
10.05Hairstory Promotes Dina Rosenbloom To Chief Executive Officer
10.05Net Sales Decrease 5% for The Clorox Company in Q3 2024
10.05Sunak says it'll take time for people to feel better
10.05Alabama second state to ban lab-grown meat
10.05Alabama second state to ban lab-grown meat
10.05Senators request more aggressive approach on HPAI countermeasures
More »